Charles Schwab Investment Management Inc Angion Biomedica Corp. Transaction History

Charles Schwab Investment Management Inc

  • $429 Billion
  • Q1 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.1 - $2.23 $50,329 - $102,031
-45,754 Closed
0 $0
Q3 2021

Nov 16, 2021
BUY
$9.31 - $13.25 $116,784 - $166,208
12,544 Added 37.77%
45,754 $448,000
Q2 2021

Aug 16, 2021
SELL
$13.02 - $17.83 $20,936 - $28,670
-1,608 Reduced 4.62%
33,210 $433,000
Q1 2021

May 17, 2021
BUY
$15.01 - $25.74 $522,618 - $896,215
34,818 New
34,818 $630,000

About Angion Biomedica Corp.

ANGN Quotes by TradingView
  • Ticker ANGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,113,300
  • Description
  • Angion Biomedica Corp., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapeutics for acute organ injuries and fibrotic diseases. The company's lead product candidate is ANG-3070, an oral tyrosine kinase receptor inhibitor in development as a treatment for fibrotic diseases, primaril...
More about ANGN
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email